TRxADE HEALTH, INC financial data

Symbol
MEDS on Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Location
2420 Brunello Trace, Lutz, FL
State of incorporation
Delaware
Fiscal year end
December 31
Former names
TRXADE GROUP, INC. (to 5/28/2021), XCELLINK INTERNATIONAL INC. (to 1/31/2014), Bluebird Exploration Co. (to 12/10/2008)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % +60.2%
Quick Ratio 11.5 % +195%
Debt-to-equity 75.4 % -92.4%
Return On Equity 45 %
Return On Assets 25.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.41M shares +12.8%
Common Stock, Shares, Outstanding 1.41M shares +106%
Entity Public Float 11.5M USD -32.3%
Common Stock, Value, Issued 14 USD +100%
Weighted Average Number of Shares Outstanding, Basic 1.41M shares +106%
Weighted Average Number of Shares Outstanding, Diluted 1.41M shares +106%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 18.7K USD -94.9%
Cost of Revenue 19.4K USD -96.8%
General and Administrative Expense 7.48M USD +723%
Operating Income (Loss) -12.8M USD -471%
Nonoperating Income (Expense) -5.77M USD -300%
Net Income (Loss) Attributable to Parent 4.22M USD +7.14%
Earnings Per Share, Basic -1.3 USD/shares +55.2%
Earnings Per Share, Diluted 11.9 USD/shares +55.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.5M USD +193%
Accounts Receivable, after Allowance for Credit Loss, Current 13.1K USD -98.4%
Inventory, Net 6.44K USD -96%
Assets, Current 12.1M USD +480%
Property, Plant and Equipment, Net 6.5K USD -89.1%
Operating Lease, Right-of-Use Asset 176K USD -81.6%
Intangible Assets, Net (Excluding Goodwill) 8.96M USD
Goodwill 5.13M USD
Assets 14.8M USD +162%
Accounts Payable, Current 726K USD -15.9%
Accrued Liabilities, Current 500K USD +33%
Contract with Customer, Liability, Current 996 USD -90%
Liabilities, Current 2.9M USD -31.9%
Operating Lease, Liability, Noncurrent 161K USD
Other Liabilities, Noncurrent 777K USD -21.4%
Liabilities 3.06M USD -39.2%
Retained Earnings (Accumulated Deficit) -26.5M USD -21.1%
Stockholders' Equity Attributable to Parent 11.8M USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.8M USD
Liabilities and Equity 14.8M USD +296%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD -994%
Net Cash Provided by (Used in) Financing Activities -13.9M USD -2140%
Net Cash Provided by (Used in) Investing Activities 27.4M USD +8133%
Common Stock, Shares Authorized 100M shares +1400%
Common Stock, Shares, Issued 1.41M shares +106%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.35M USD +3936%
Interest Paid, Excluding Capitalized Interest, Operating Activities 62.4K USD +4474%
Deferred Tax Assets, Valuation Allowance 5.94M USD +47.3%
Operating Lease, Liability 194K USD -80.4%
Depreciation 500 USD -82.3%
Lessee, Operating Lease, Liability, to be Paid 241K USD -79.7%
Operating Lease, Liability, Current 32.6K USD -84.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 55.3K USD -82%
Lessee, Operating Lease, Liability, to be Paid, Year One 53.7K USD -82%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47K USD -76.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.9K USD -82%
Deferred Tax Assets, Operating Loss Carryforwards 5.8M USD +43.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 48.6K USD -74.3%
Operating Lease, Payments 13.6K USD
Additional Paid in Capital 38.3M USD +86%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.08M USD +50.8%
Interest Expense 1.23M USD +211%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%